Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins
Gillian Duncan, … , Craig McCormick, Frank Tufaro
Gillian Duncan, … , Craig McCormick, Frank Tufaro
Published August 15, 2001
Citation Information: J Clin Invest. 2001;108(4):511-516. https://doi.org/10.1172/JCI13737.
View: Text | PDF
Perspective

The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins

  • Text
  • PDF
Abstract

Authors

Gillian Duncan, Craig McCormick, Frank Tufaro

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
A working model of mammalian bone development. Hypothetical representati...
A working model of mammalian bone development. Hypothetical representation of the growth plate during endochondral bone formation (adapted from ref. 44). Prehypertrophic chondrocytes (pre) localized within the growth plate produce a cell signaling molecule, Ihh, which diffuses to the receiving cells via HS proteoglycans (HSPGs) that are glycosylated by EXT1 and EXT2 HS-Pol activity. By analogy with what is known about the Hh signaling cascade in Drosophila, it is likely that signaling is initiated when Ihh binds to a two-component receptor/signal transducer complex on the surface of a responding cell, which is composed of both Patched (Ptc) and Smoothened (Smo). When Ihh binds to Ptc, Smo is de-repressed and additional intracellular components of the signaling pathway are activated (reviewed in ref. 29). Recent work suggests that there may be an additional member in this cascade, Hedgehog-interacting protein (Hip), which could act to attenuate Ihh signaling. In bone, Ptc is expressed on the osteogenic cells of the perichondral region, and Ihh binding induces chondrocyte proliferation by upregulating a second signaling molecule, PTHrP. PTHrP binds to the PTH/PTHrP receptor on a subpopulation of proliferating (pro) and prehypertrophic chondrocytes, thereby inducing production of Bcl-2, a well known antiapoptotic protein. In the absence of negative feedback, chondrocytes differentiate into hypertrophic chondrocytes (hyp), which undergo apoptosis and are then replaced by bone-forming osteoblasts. According to this model, hereditary exostosis formation would occur when a chondrocyte bearing a germline mutation in either EXT1 or EXT2 develops an inactivating “hit” in the second copy of the same gene, thereby abrogating HS expression. Clonal expansion of this mutant chondrocyte would then lead to a local perturbation in Ihh diffusion with, as a result, release from negative feedback control. The neighboring population of proliferating chondrocytes would therefore undergo premature chondrocyte differentiation, apoptosis, and subsequent ossification.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts